Florian Castet

9PUBLICATIONS
75CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyPredictive and prognostic markersLiquid biopsiesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 12, 2025
Durvalumab in Advanced Biliary Tract Cancer: Real-World Data From a Large Cohort of Patients Across Multiple International Centers.

Margherita Rimini, Lorenzo Fornaro, Masafumi Ikeda

|Aug 26, 2025
Ivosidenib for IDH1-Mutant Intrahepatic Cholangiocarcinoma: Insights From a Multicenter Real-World Study.

Monica Niger, Margherita Rimini, Florian Castet

|Jun 17, 2025
A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The MAGIC-D Index.

Mara Persano, Margherita Rimini, Francesca Salani

|Jul 30, 2024
Clinical Value of Liquid Biopsy in Patients with FGFR2 Fusion-Positive Cholangiocarcinoma During Targeted Therapy.

Alberto González-Medina, Maria Vila-Casadesús, Marina Gomez-Rey

|Apr 08, 2024
Management of biliary tract cancers in early-onset patients: A nested multicenter retrospective study of the ACABI GERCOR PRONOBIL cohort.

Antoine Lebeaud, Leony Antoun, Jane-Rose Paccard

|Nov 14, 2022
Human Metastatic Cholangiocarcinoma Patient-Derived Xenografts and Tumoroids for Preclinical Drug Evaluation.

Queralt Serra-Camprubí, Helena Verdaguer, Winona Oliveros

Pageof 2